Drug Trial Radar · NCT00934245
Direct and Indirect Protection by Influenza Vaccine Given to Children in India
Last checked: Nov 20, 2026Latest source record: Feb 22, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,598
Actual
Start
Sep 2009
Primary completion
Jul 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- Wayne Sullender, M.D.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- All India Institute of Medical Sciences; Centers for Disease Control and Prevention
- First posted
- Jul 8, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study described here will immunize children with trivalent influenza vaccine (TIV) and determine whether this reduces influenza illness among the immunized children and their older family members. The comparison or control group for the children receiving influenza vaccine will be children immunized with inactivated poliovirus vaccine (IPV). The study will also provide information on the amount of disease produced by influenza in the study population.
Conditions
- Influenza
Interventions
Inactivated Trivalent Influenza VaccineBiological
Vaccine administration will occur twice, one month apart, in the first year of participation in the study. This will occur as TIV vaccine becomes available in India, in the early autumn. Subsequent years will provide one immunization. Due to the inclusion of the pandemic 2009 influenza A H1N1 virus in the 2010-2011 northern hemisphere vaccine formulation and recommendations that children should receive 2 doses of this vaccine this study will administer 2 doses of vaccine in the second year of the study.
Inactivated polio vaccine (IPV)Biological
Vaccine administration will occur twice, one month apart, in the first year of participation in the study to parallel administration of TIV (experimental intervention). Subsequent years will provide one immunization except 2011 schedule modified to accommodate changes in TIV schedule as per above..
Primary outcomes
What the sponsor says the trial is designed to measure.
- Laboratory-confirmed influenza infection in vaccinated childTime frame: 1 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Comprehensive Rural Health Services Project (CRHSP)
Ballabgarh, Haryana, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.